159 related articles for article (PubMed ID: 31686259)
1. Structural and solution chemistry, antiproliferative effects, and serum albumin binding of three pseudohalide derivatives of auranofin.
Cirri D; Fabbrini MG; Massai L; Pillozzi S; Guerri A; Menconi A; Messori L; Marzo T; Pratesi A
Biometals; 2019 Dec; 32(6):939-948. PubMed ID: 31686259
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships in a series of auranofin analogues showing remarkable antiproliferative properties.
Landini I; Massai L; Cirri D; Gamberi T; Paoli P; Messori L; Mini E; Nobili S
J Inorg Biochem; 2020 Jul; 208():111079. PubMed ID: 32497830
[TBL] [Abstract][Full Text] [Related]
3. New Variations on the Theme of Gold(III) C
Carboni S; Zucca A; Stoccoro S; Maiore L; Arca M; Ortu F; Artner C; Keppler BK; Meier-Menches SM; Casini A; Cinellu MA
Inorg Chem; 2018 Dec; 57(23):14852-14865. PubMed ID: 30457328
[TBL] [Abstract][Full Text] [Related]
4. Gold-Based Metal Drugs as Inhibitors of Coronavirus Proteins: The Inhibition of SARS-CoV-2 Main Protease by Auranofin and Its Analogs.
Massai L; Grifagni D; De Santis A; Geri A; Cantini F; Calderone V; Banci L; Messori L
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421689
[TBL] [Abstract][Full Text] [Related]
5. Auranofin and its Analogues Show Potent Antimicrobial Activity against Multidrug-Resistant Pathogens: Structure-Activity Relationships.
Marzo T; Cirri D; Pollini S; Prato M; Fallani S; Cassetta MI; Novelli A; Rossolini GM; Messori L
ChemMedChem; 2018 Nov; 13(22):2448-2454. PubMed ID: 30252208
[TBL] [Abstract][Full Text] [Related]
6. X-ray absorption spectroscopy studies of the adducts formed between cytotoxic gold compounds and two major serum proteins.
Messori L; Balerna A; Ascone I; Castellano C; Gabbiani C; Casini A; Marchioni C; Jaouen G; Congiu Castellano A
J Biol Inorg Chem; 2011 Mar; 16(3):491-9. PubMed ID: 21181484
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic Evaluations of the Effects of Auranofin Triethylphosphine Replacement with a Trimethylphosphite Moiety.
Ronga L; Tolbatov I; Giorgi E; Pisarek P; Enjalbal C; Marrone A; Tesauro D; Lobinski R; Marzo T; Cirri D; Pratesi A
Inorg Chem; 2023 Jul; 62(26):10389-10396. PubMed ID: 37342994
[TBL] [Abstract][Full Text] [Related]
8. Chemical Modification of Auranofin Yields a New Family of Anticancer Drug Candidates: The Gold(I) Phosphite Analogues.
Cirri D; Geri A; Massai L; Mannelli M; Gamberi T; Magherini F; Becatti M; Gabbiani C; Pratesi A; Messori L
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770719
[TBL] [Abstract][Full Text] [Related]
9. Organogold(III) compounds as experimental anticancer agents: chemical and biological profiles.
Massai L; Cirri D; Michelucci E; Bartoli G; Guerri A; Cinellu MA; Cocco F; Gabbiani C; Messori L
Biometals; 2016 Oct; 29(5):863-72. PubMed ID: 27476157
[TBL] [Abstract][Full Text] [Related]
10. Seleno-auranofin (Et3PAuSe-tagl): synthesis, spectroscopic (EXAFS, 197Au Mössbauer, 31P, 1H, 13C, and 77Se NMR, ESI-MS) characterization, biological activity, and rapid serum albumin-induced triethylphosphine oxide generation.
Hill DT; Isab AA; Griswold DE; DiMartino MJ; Matz ED; Figueroa AL; Wawro JE; DeBrosse C; Reiff WM; Elder RC; Jones B; Webb JW; Shaw CF
Inorg Chem; 2010 Sep; 49(17):7663-75. PubMed ID: 20704360
[TBL] [Abstract][Full Text] [Related]
11. Structural and solution chemistry, protein binding and antiproliferative profiles of gold(I)/(III) complexes bearing the saccharinato ligand.
Maiore L; Cinellu MA; Michelucci E; Moneti G; Nobili S; Landini I; Mini E; Guerri A; Gabbiani C; Messori L
J Inorg Biochem; 2011 Mar; 105(3):348-55. PubMed ID: 21421122
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt
Tolbatov I; Cirri D; Marchetti L; Marrone A; Coletti C; Re N; La Mendola D; Messori L; Marzo T; Gabbiani C; Pratesi A
Front Chem; 2020; 8():812. PubMed ID: 33195032
[TBL] [Abstract][Full Text] [Related]
13. The mode of action of anticancer gold-based drugs: a structural perspective.
Messori L; Scaletti F; Massai L; Cinellu MA; Gabbiani C; Vergara A; Merlino A
Chem Commun (Camb); 2013 Oct; 49(86):10100-2. PubMed ID: 24045294
[TBL] [Abstract][Full Text] [Related]
14. A complex bearing TSPO PIGA ligand coordinated to the [Au(PEt
Chiaverini L; Baglini E; Mannelli M; Poggetti V; Da Settimo F; Taliani S; Gamberi T; Barresi E; La Mendola D; Marzo T
Biometals; 2023 Oct; 36(5):961-968. PubMed ID: 36869967
[TBL] [Abstract][Full Text] [Related]
15. Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds.
Messori L; Abbate F; Marcon G; Orioli P; Fontani M; Mini E; Mazzei T; Carotti S; O'Connell T; Zanello P
J Med Chem; 2000 Sep; 43(19):3541-8. PubMed ID: 11000008
[TBL] [Abstract][Full Text] [Related]
16. Reactions of Auranofin and Its Pseudohalide Derivatives with Serum Albumin Investigated through ESI-Q-TOF MS.
Pratesi A; Cirri D; Ciofi L; Messori L
Inorg Chem; 2018 Sep; 57(17):10507-10510. PubMed ID: 30109928
[TBL] [Abstract][Full Text] [Related]
17. Reactions of gold(III) complexes with serum albumin.
Marcon G; Messori L; Orioli P; Cinellu MA; Minghetti G
Eur J Biochem; 2003 Dec; 270(23):4655-61. PubMed ID: 14622252
[TBL] [Abstract][Full Text] [Related]
18. A new structural transition of serum albumin dependent on the state of Cys34. Detection by 1H-NMR spectroscopy.
Christodoulou J; Sadler PJ; Tucker A
Eur J Biochem; 1994 Oct; 225(1):363-8. PubMed ID: 7925457
[TBL] [Abstract][Full Text] [Related]
19. Organotin(IV) complexes derived from Schiff base N'-[(1E)-(2-hydroxy-3-methoxyphenyl)methylidene]pyridine-4-carbohydrazone: synthesis, in vitro cytotoxicities and DNA/BSA interaction.
Hong M; Geng H; Niu M; Wang F; Li D; Liu J; Yin H
Eur J Med Chem; 2014 Oct; 86():550-61. PubMed ID: 25216377
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, chemical characterization, and biological evaluation of a novel auranofin derivative as an anticancer agent.
Cirri D; Massai L; Giacomelli C; Trincavelli ML; Guerri A; Gabbiani C; Messori L; Pratesi A
Dalton Trans; 2022 Sep; 51(35):13527-13539. PubMed ID: 36000524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
